Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

962 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults.
Giustina A, Barkan A, Chanson P, Grossman A, Hoffman A, Ghigo E, Casanueva F, Colao A, Lamberts S, Sheppard M, Melmed S; Pituitary Society; European Neuroendocrine Association. Giustina A, et al. Among authors: sheppard m. J Endocrinol Invest. 2008 Sep;31(9):820-38. doi: 10.1007/BF03349263. J Endocrinol Invest. 2008. PMID: 18997495 Review.
Diagnosis and treatment of acromegaly complications.
Giustina A, Casanueva FF, Cavagnini F, Chanson P, Clemmons D, Frohman LA, Gaillard R, Ho K, Jaquet P, Kleinberg DL, Lamberts SW, Lombardi G, Sheppard M, Strasburger CJ, Vance ML, Wass JA, Melmed S; Pituitary Society and the European Neuroendocrine Association. Giustina A, et al. Among authors: sheppard m. J Endocrinol Invest. 2003 Dec;26(12):1242-7. doi: 10.1007/BF03349164. J Endocrinol Invest. 2003. PMID: 15055479
Consensus statement: medical management of acromegaly.
Melmed S, Casanueva F, Cavagnini F, Chanson P, Frohman LA, Gaillard R, Ghigo E, Ho K, Jaquet P, Kleinberg D, Lamberts S, Laws E, Lombardi G, Sheppard MC, Thorner M, Vance ML, Wass JA, Giustina A. Melmed S, et al. Among authors: sheppard mc. Eur J Endocrinol. 2005 Dec;153(6):737-40. doi: 10.1530/eje.1.02036. Eur J Endocrinol. 2005. PMID: 16322377
Pasireotide versus octreotide in acromegaly: a head-to-head superiority study.
Colao A, Bronstein MD, Freda P, Gu F, Shen CC, Gadelha M, Fleseriu M, van der Lely AJ, Farrall AJ, Hermosillo Reséndiz K, Ruffin M, Chen Y, Sheppard M; Pasireotide C2305 Study Group. Colao A, et al. Among authors: sheppard m. J Clin Endocrinol Metab. 2014 Mar;99(3):791-9. doi: 10.1210/jc.2013-2480. Epub 2014 Jan 13. J Clin Endocrinol Metab. 2014. PMID: 24423324 Free PMC article. Clinical Trial.
The critical parameters in GH excess.
Sheppard MC. Sheppard MC. J Endocrinol Invest. 2005;28(5 Suppl):92-5. J Endocrinol Invest. 2005. PMID: 16114283 Review.
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF, Davis RJ. Trainer PJ, et al. Among authors: sheppard mc. N Engl J Med. 2000 Apr 20;342(16):1171-7. doi: 10.1056/NEJM200004203421604. N Engl J Med. 2000. PMID: 10770982 Free article. Clinical Trial.
GH and mortality in acromegaly.
Sheppard MC. Sheppard MC. J Endocrinol Invest. 2005;28(11 Suppl International):75-7. J Endocrinol Invest. 2005. PMID: 16625851 Review.
Growth hormone and its disorders.
Ayuk J, Sheppard MC. Ayuk J, et al. Among authors: sheppard mc. Postgrad Med J. 2006 Jan;82(963):24-30. doi: 10.1136/pgmj.2005.036087. Postgrad Med J. 2006. PMID: 16397076 Free PMC article. Review.
962 results